$HONA

Honeywell Aerospace analysis: what does Morgan Stanley’s upgrade tell investors?

Morgan Stanley upgraded Honeywell Aerospace (HONA) to Overweight with a $205 price target, citing a 35% valuation discount to peers. The stock rose 7.51% to $172.84 on the news. Analysts note supply chain issues and negative book equity as risks, while management expects improvements by 2027-2028.

Original reporting
Published Aug 19, 2026, 6:06 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 19, 2026, 6:19 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefMarket movers
Primary signal
$HONA
Bullish
high confidence
Mentioned
$HONA
Relevance
7/10
AlphAI data visualization · based on investing.com
Decision brief

The 30-second read

$HONABullishHigh
01

Why it matters

The upgrade provides a clear catalyst for short‑term buying, but investors should monitor execution of supply‑chain improvements.

02

Market read

A notable analyst upgrade with a sizable price target and immediate stock rally makes this a high‑actionability event for traders.

03

What to watch

Potential structural supply‑chain issues could delay recovery.

Relevance 7/10Novelty 7/10Timing: today

Background

Morgan Stanley's upgrade follows concerns over Honeywell Aerospace's post‑spin‑off balance sheet and recent earnings revisions.

Company-level read

Ticker impact

$HONABullishHigh confidence
Context

Morgan Stanley upgraded Honeywell Aerospace to Overweight with a $205 price target, driving a 7.5% intraday rise.

Expected impact

Potential rally toward $205 target over the next weeks.

Evidence & confidence

Valuation discount to peers and supply‑chain fixes provide a margin of safety, outweighing equity concerns.

Market effects

Highlights undervaluation in aerospace sector, may spur re‑rating of peers.

U.S. aerospace stocks could see broader buying pressure.

Limited to aerospace and industrial investors.

Counterpoint

Negative equity and recent earnings downgrades suggest caution.

Key entities

  • Morgan Stanley

    Provided the Overweight upgrade and $205 price target.

  • Honeywell Aerospace

    Subject of the upgrade and recent price surge.

Related articles

$HONAHighAI 9/10

A $1.5 Trillion Defense Budget Is on the Table. Here's the 1 Defense Stock I'd Buy First.

Honeywell Aerospace (HONA) is highlighted as a potential investment opportunity due to increased global defense spending and strong demand for aircraft parts. The company reported Q2 revenue of $4.5B, up 5% YoY, but EPS fell 71% to $0.78. It adjusted full-year guidance, reducing organic growth and EBIT expectations. Analysts see upside, with an average price target of $213, 35% above current levels. The company's backlog grew 9% YoY to $18.2B, driven by defense modernization programs.

$HONMed

Honeywell Is Now Three Companies. Here's Which Piece I'd Actually Own.

Honeywell has split into three companies: Honeywell Technologies (HON), Solstice Advanced Materials (SOLS), and Honeywell Aerospace (HONA). Honeywell Technologies, led by CEO Vimal Kapur, reported strong automation sector growth with 16% order increase and 10% earnings growth. Solstice Advanced Materials showed 11% sales growth and 23% EPS increase, while Honeywell Aerospace lowered guidance.

$HONAHighAI 8/10

Honeywell Aerospace upgraded to Overweight by Morgan Stanley

Honeywell Aerospace (HONA) shares rose 5.5% after Morgan Stanley upgraded it to Overweight with a $205 price target. The firm cited attractive valuations at 16.8x 2028 P/FCF and 11.4x 2028 EV/EBITDA, despite operational challenges and legal investigations. The company reported Q2 sales of $4.52B and an $18.2B backlog but cut full-year guidance due to supply chain issues.

$HONAHigh

Honeywell Aerospace Stock Upgraded to Overweight Following Sell-Off - Honeywell Aerospace (NASDAQ:HONA)

Morgan Stanley upgraded Honeywell Aerospace (HONA) to Overweight with a $205 price target, citing a 25% sell-off post-spin-off and discounted valuation. HONA trades at 16.8x 2028 P/FCF and 11.4x 2028 EV/EBITDA, 35-38% below peers. Q2 sales were $4.52B, up 5% organically, but supply chain issues led to trimmed guidance. CEO Jim Currier acknowledged execution delays but noted localized issues and efforts to dual-source suppliers and expand capacity.